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Abstract
Background and objectives: Cervical cancer is ranked as the third most prevalent cancer that affects women all over the
world and Pap smear seems to be the single most critical intervention to prevent cervical cancer. In the present study, the
effects of demographic factors (age, education level, job, income level, marriage age, pregnancy, child number,
breastfeeding, and menopause), insurance type, disease history and screening (sono and mammography, breast problem) and cancer information on Pap smear screening and behavior stage of change were investigated and modeled using
an artiﬁcial neural network model (ANN).
Materials and methods: Data were collected from a descriptive-analytical cross-sectional study. This research was
conducted on 1898 female employees of governmental agencies of Birjand, a city located in the east of Iran. The
questionnaire consisted of four parts (socioeconomic, reproductive characteristics, information about cervical cancer
screening, and stage of change for cervical cancer screening). Multilayer feed-forward back-propagation neural networks
were used to detect the patterns between variables using a neural network with 14 inputs and one output. To ﬁnd out the
neural network with the minimum sum of squared errors, we evaluated the performance of all neural networks using
varying algorithms and numbers of neurons in the hidden layer. For this purpose, the data collected from 1898 women
were analyzed using SPSS-22 software.
Results: In the optimal ANN model, the variables of marriage age, age, breastfeeding, and the number of children were
identiﬁed as the most signiﬁcant factors with 18.3, 16.3, 7.3, and 7.3 percent, respectively, whereas the history of cancer,
job, pregnancy, and menopause had importance of lower than 5 percent.
Conclusion: Our ﬁndings showed that among many associated variables, the marriage age, age, breastfeeding, and the
number of children were the most important predictors for the behavioral stage of change. Thus, it seems, focusing on
these factors may lead to the adoption of effective programs and policies to improve cervical cancer screening practices
in women.
Keywords: Artiﬁcial neural network, Cervical cancer, Pap smear, Predicting factor, Screening

1. Introduction

C

ancers are the leading cause of death worldwide particularly in women in both high-income countries and middle-income countries [1].
Among the cancers, cervical cancer is one of the
most common gynecological malignancies which
were relatively well controlled for several decades in

many high-income countries however; it remains
the leading cause of cancer-related deaths in 42
countries, most of which are low-income and lowermiddle-income countries (LMICs) [2]. Approximately 85% of women who were diagnosed with
cervical cancer and 88% of those who died from
cervical cancer live in LMICs [1]. Based on the
World Health Organization (WHO) report, low and
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middle-income countries have the highest cervical
cancer rates due to different factors including
irregular doctor visits, low access to health facilities,
and unaffordable health care [3]. Based on the International Agency for Research on Cancer (IARC),
globally more than 569,000 new cases of cervical
cancer are reported, and 311,000 women deaths
occur annually due to cervical cancer [4,5].
The most widely accepted, method of cervical
cancer screening in the early stages of the disease,
which is inexpensive, simple, quick, and relatively
painless is the Papanicolaou smear (Pap smear) [6].
Cervical cancer can be prevented through primary,
secondary, and tertiary prevention methods [7].
Primary prevention method includes education for
having safe sexual practices and human papillomavirus (HPV) vaccination [8]. HPV vaccination is
considered as one of the proven approaches to
prevent cervical cancer however, in many countries,
implementation of HPV vaccination is limited (4).
The secondary prevention method involves cervical
cancer screening of asymptomatic patients and
management of precancerous lesions before they
turn into cancer via Pap smear [9,10]. Experiences
from the developed world show, broad and effective
coverage of screening programs can lead to a
reduction in cervical cancer incidences and mortality associated with this cancer [6,11]. The screening
programs for cervical cancer in Iran are free of
charge and widely accessible in public health centers however, Iranian women commonly avail these
cervical cancer screening services resulting in a high
rate of death from cervical cancer in Iran [12].
Several epidemiological studies have shown the
role of risk factors such as sexually transmitted infections [13], reproductive and behavioral factors
[14] in the incidence of cancer which among them,
HPV infection is the most important risk factor
[15,16]. Also, sociodemographic factors which inﬂuence women's screening practices include age,
marital status, education level, employment status,
smoking, long-term hormonal contraceptive use,
and income level [17,18], which some of them are
modiﬁable variables and can impact the well-being
of individuals [19].
Since decision-making processes for Pap smear
screening are very complex and women may be in
different stages of readiness of adopting a behavior
change hence, the transtheoretical model (TTM) of
behavior change was used in this study. Also, based
on the TTM model, health-seeking behavior is a
dynamic process. This model has four basic
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principles: the stages of change, self-efﬁcacy, decisional balance, and processes of change [20,21].
By modeling the relationships of neurons in the
human brain, artiﬁcial neural networks (ANN) were
identiﬁed, predicted, and classiﬁed the pattern of
association between variables [22]. This type of
modeling has been used in psychiatry, medicine,
etc. with a lower sum of square error and higher
correlation coefﬁcients than conventional models
such as the response surface methodology (RSM)
[23,24].
Results from a study conducted by Schaffter et al.,
(2020) on 144,231 mammograms from 85,580 American women and 166,578 examinations from 68,008
Swedish women showed no single artiﬁcial intelligence algorithm outperformed the US community
radiologist benchmarks [25]. Another study was
conducted by Natarajan et al. (2019) on 231 patients
for diabetic retinopathy screenings. In this study,
the use of an ofﬂine artiﬁcial intelligence system on
a smartphone-enabled screening of referable diabetic retinopathy in remote areas where services of
an ophthalmologist are unavailable with sensitivity
and speciﬁcity of 100.0% and 88.4%, respectively vs.
85.2% and 92.0% with ophthalmologist grading
using the same images, respectively [26]. Also, Bhatt
et al., (2021) used singular multi-class classiﬁcation
methodology and Progressive Resizing and Transfer
Learning on Deep Neural Network models for cervical cells from Whole Slide Images (WSI). The
images showed accuracy (99.70%), precision
(99.70%), and recall (99.72%) F- Beta (99.63%), and
Kappa scores (99.31%), which supersede the scores
obtained through principal methodologies [27].
Using the data obtained from the Behavioral Risk
Factor Surveillance System (BRFSS) database of the
Centers for Disease Control and Prevention,
Raghupathiet al., (2012) used neural networks to
analyze the combined inﬂuence of multiple behavioral habits on chronic diseases. Neural networks
have the advantage for analyzing large and complex
data sets which herein, makes it possible to identify
populations of patients in behavioral risk categories
for delivery of wellness programs relating to chronic
diseases [28].
1.1. Objectives
In this study, we used the multilayer feed-forward
back-propagation neural network as one of the
popular neural networks in predicting and
modeling [29]. For this purpose, we used 80% of the
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observed data in the training set and the remaining
20% in the model evaluation.

2. Methods
This study was descriptive-analytical and crosssectional research in which the factors related to the
stage of change in cervical cancer screening were
investigated. The sample populations of this study
were female employees of governmental agencies in
Birjand, a city located in the east of Iran. The sampling was conducted using a survey and the selfadministered questionnaire was completed by 1898
employed women. Inclusion criteria for participation in this study included female employees who
were married and aged between 20 and 65 years,
with no personal history of cervical cancer, and
willingness to participate in the survey. Therefore,
we excluded females with a history of hysterectomy
or gynecological cancer and women <20 years old
and single.
The data were collected using a four-part questionnaire. The ﬁrst section contains socioeconomic
characteristics (age, education, marital status, job,
family income, and insurance). The second part of
the questionnaire included questions about reproductive and pregnancy characteristics (marriage
age, ﬁrst gestational age, number of children,
lactation, and menopause status). The third section
of the questionnaire consisted of information about
cervical cancer, the history of problems in breasts,
and the history of cancer in the close family members, the history of referral for mammography or
ultrasound. The four section of the questionnaire
consisted of women's performance and intention
regarding screening behaviors of Pap smear.
To evaluate cervical cancer screening behavior
stages of change, we used the single item with 3
choices as a stage of behavior changes that was
adapted from the mammography stage of change
scale described elsewhere [30,31]. Thus, three stages
of Pap smear adoption are deﬁned as 1-Precontemplation (women who have never had any
prior Pap smear and are not planning to get a Pap
smear in the coming year) or Relapse (women who
have had one or more Pap smears in the previous
years but do not intend to have another one in the
coming year), 2-Contemplation (women who are
planning to get a Pap smear in the coming year, but
have not done yet), 3-Action (women who have had
a Pap smear with age-speciﬁc interval and intent to
have another one) or Maintenance (women who
have two or more Pap smears on schedule and
intend to continue). The content validity of this scale
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was assessed by summing up the opinions of the
expert panel (three health educators, four gynecologists and midwives, two epidemiologists, and one
community health nurse). The reliability of this item
was also assessed by 20 women who matched with
the sample and were out of the target group of this
study.
2.1. Statistical analysis
In regression analysis, restricted assumptions like
normality may be avoided when predicting variables that are categorical such as our study. One of
the best ways to overcome this dilemma is using
models like ANN models. Since a sufﬁcient sample
size was available in the present study, the ANN
model seemed to be one of the best analysis
methods. The three main components of the neural
network are neuron, structure, and weight. The
number of input and output layer neurons is
determined based on the number of input and
response variables. Therefore, the structure of the
neural network is determined according to the
number of neurons in a hidden layer, the type of
connection between neurons in this layer and other
layers, and their connection functions [32]. The
proper connection function was selected between
hyperbolic tangent or sigmoid, to connect the neurons of the input and hidden layers and linear, hyperbolic tangent, SoftMax, or sigmoid functions to
connect the neurons of the hidden and output layers
in our study [33,34]. Subsequently, we determined
the number of optimal neurons in the hidden layer
by increasing them to 46 neurons in a network that
used the optimal function to connect the neurons of
different layers. To avoid the effect of random
weight allocation and random correlations, we
repeated each grid three times and used their mean
sum of square errors as an appropriate indicator in
the model evaluation. In the network training, 1519
data were used and the model was conﬁrmed using
the remaining 379 data. The performance of the
optimal ANN was presented according to the
sensitivity, speciﬁcity, and accuracy area under the
ROC curve (AUC) results. Finally, the importance of
input variables including age, education level, job,
income level, marriage age, pregnancy, child number, breastfeeding, and menopause, insurance type,
disease history (sono and mammography, breast
problem, and cancer), and cancer information was
determined on Pap smear screening behavior stage
of change (output variable). All analyses were performed using Statistical Package for Social Sciences
version 22 (SPSS Inc., Chicago, Illinois, USA).

3. Results
To determine the best function that can connect
different layers of the neural network among the
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different functions in the connecting input, hidden,
and output layers; we examined the results of the
neural network with 2 neurons in the hidden layer
(Fig. 1A). As can be seen, the neural network with

Fig. 1. A) The mean square error of ANN models in both training and validation phase for different transfer functions; B) The mean square error of
selected ANN transfer function models in both training and validation phase for different hidden neurons.
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0.67
0.69
0.632
0.644
32
223 (97%)
0 (0%)
0
4
7
0 (0%)
0
42
40

151
815 (95.3%)

0.72
0
20 (17.7%)
392
0
79 (16.8%)

Precontemplation
-Relapse
Contemplation
Action-Maintenance

Contemplation

93

0.598

AUC
ActionMaintenance
PrecontemplationRelapse

Contemplation

Validation set (n ¼ 379)

PrecontemplationRelapse

ActionMaintenance
Training set (n ¼ 1519)

Table 1. Power of the different variables for predicting Pap Smear Screening behavior based on triples threshold values in training and validation groups separately.

Sensitivity

0.48

Speciﬁcity
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0.48
0.43
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hyperbolic tangent between the neurons of the
input and hidden layers and sigmoid function
between the neurons of the hidden and output
layers had the least mean square error in both the
training and validation sets. Furthermore,
increasing the number of neurons in the hidden
layer did not have an impact on improving the
performance of the network (Fig. 1B). Therefore,
the neural network with two neurons in the hidden layer and the hyperbolic tangent function for
connecting the input-hidden and the sigmoid
function for connecting the hidden-output layers
with 2.737 e-01 and 2.4996e-01 total mean square
errors are optimal in training and validation sets,
respectively (Fig. 1). This neural network was able
to predict the Pap smear behavior stage of change
effectively using these variables (Fig. 2).
As shown in Table 1, 79 participants out of 471
participants and 20 participants out of 113 participants for the precontemplation - Relapse stage in
training and validation sets were correctly categorized by the perfect ANNs model. This model
also detected 815 participants out of 855 and 223
participants out of 230 participants for the ActionMaintenance stage in training and validation sets
by the variables mentioned in the study, but the
optimal model was not able to predict women in
the contemplation stage correctly. Table 1 also
revealed that sensitivity, speciﬁcity, and AUC in
the validation set were higher than 0.65, 0.43, and
0.59, respectively.

Fig. 2. Roc curve of the Artiﬁcial Neural Network model.

E. ALLAHYARI ET AL.
ANNS FOR PREDICTING PAP SMEAR SCREENING

15
ORIGINAL ARTICLE

BioMedicine
2022;12(2):10e18

Fig. 3. The importance variables from the selected Artiﬁcial Neural Network.

The importance of pregnancy characters, socioeconomic factors, and disease screening information
were respectively 40.10, 39.80, and 20.10 percent
(Fig. 3). Among the variables, marriage age, age,
breastfeeding, children number, and education
were identiﬁed as the most important factors with
18.3, 16.3, 7.3, 7.3, and 7.2 percent, respectively.
As you see in Table 2, women who are 30 years old
or younger are often in Precontemplation -Relapse
stage and similar stage. Women who are older than
30 years old are often in the Action-Maintenance
stage. Women in the Action-Maintenance stage had
signiﬁcantly lower marriage age than other participants. Most mothers that had a baby and experienced breastfeeding were in the ActionMaintenance stage, although about 64 percent of
mothers that had no baby and breastfeeding were in
Precontemplation -Relapse or Contemplation stage.

4. Discussion
ANN models including many different architectures and methods are widely used in many medical
applications with better accuracy in results.
Previous studies investigated manual screening
methods. Cervigram images in the detection of
cervical cancer improved the accuracy of predicting
cancer susceptibility, recurrence, and mortality by
using ANN models [35e38], however, in this study,

ANN was considered as the modeling of predicting
Pap smear screening behavior stage.
Our result showed that women who are younger
than 30 years of age are often in the Precontempltion-relapse stage. Those who are in their
30s or older are often in the action-maintenance
stage.
Our result was supported by Tung et al. (2019)
who showed more of the older participants aged
40e65 was in a more advanced stage (Action/
Maintenance) than younger women and Abbas et al.
(2021) who indicated that 67.8% of women were in
the Precontemplation Stage of change for performing the Pap smear [39,40]. This is in contrast with the
results obtained by Krok-Schoen et al. (2016) which
was conducted on 90 women living in Ohio Appalachian and showed that women who are younger
than 50 years old are in the action stage in the second visit as well as the results obtained by Studts
et al. (2013) who did a study on 345 Appalachian
women aged 40e64 years [41,42].
There may be a greater likelihood of obstetric and
gynecological problems with aging women who
would likely visit more often health clinics and undergo cancer screening. Another possible explanation is that young women are more likely to be
unmarried and the gynecological care they receive
(Pap test) before marriage may be not be acceptable
[43].
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Table 2. Comparing pap smear behavior stage between different marriage age, age, breast feeding, child number, education, and income categories.
Variables

Age
20e30
30e40
40e50
50
Marriage age
Breast feeding
No
Yes
Child number
0
1
2
3
4
Education
Under diploma
Diploma
Associate
Bachelor
Master or higher

PrecontemplationRelapse

Contemplation

ActionMaintenance

P-Value

n

%

n

%

n

%

85
262
174
63
23.46 ± 3.64

46.7
28.6
28.4
33.5

42
119
53
15
24.07 ± 4.03

23.1
13
8.6
8

55
534
386
110
22.95 ± 3.61

30.2
58.4
63
58.5

<0.001

154
430

44.5
27.7

68
161

19.7
10.4

124
961

35.8
61.9

<0.001

138
159
173
82
32

44.7
27
26.7
31.2
35.2

65
88
50
20
6

21
15
7.7
7.6
6.6

106
341
424
161
53

34.3
58
65.5
61.2
58.2

<0.001

25
57
73
338
91

33.8
30.5
33.2
30.3
30.1

3
22
24
146
34

4.1
11.8
10.9
13.1
11.3

46
108
123
631
177

62.2
57.8
55.9
56.6
58.6

0.57

<0.001b,

g

a: signiﬁcant between Precontemplation- Relapse and Contemplation.
b: signiﬁcant between Precontemplation- Relapse and Action- Maintenance.
g: signiﬁcant between Contemplation and Action- Maintenance.

Also, people in the action-maintenance stage had
signiﬁcantly lower marriage age than other
participants.
Our result is consistent with a community-based
cross-sectional study by Aynalem et al. (2020) which
was performed on 822 women in the Amhara region, Northwest Ethiopia who had started sexual
intercourse at age of 16 and younger and were more
likely to utilize cervical cancer screening as
compared to those women who had started sexual
intercourse after their age of 16 years [44] and it is in
contrast with National Survey of Family Growth
(NSFG) study stratiﬁed by age (15e17, 18e20,
21e29) and sexual activity by Henderson et al. (2013)
that showed among females ages 15e17, the proportion screened decreased from 23% to 12% [45].
The possible explanation is that women who start
their sexual intercourse earlier have increased lifetime sexual activities and likely experience an
increased chance of being infected with sexually
transmitted diseases (STD) and abnormal Pap test
results which in turn lead to visit health facilities.
Our study indicated that most mothers who had a
baby and experienced breastfeeding were in the
action-maintenance stage.
This is following a cross-sectional study by Visanuyothin et al. (2015) on 675 women aged 30e60

years who found those who had children were more
likely to be caregivers. Also, the study conducted by
Buki et al. (2007) on 467 Latina women [46,47] and is
inconsistent with a qualitative study by Haji Rasul
et al. (2016) on 22 women that showed multiple fullterm pregnancies did not affect cervical cancer
screening [48].
It is explainable that previous contact with
reproductive health services in earlier parity of
women may increase their awareness about consequences of cervical cancer and they have less fear
and embarrassment about undergoing a Pap smear
test than the women who have no children. Therefore, the utilization of screening services in the form
of gynecological checkups can be directly related to
the parity of women [49].

5. Conclusion
In conclusion, our ﬁndings showed that among
many associated variables, the marriage age, age,
breastfeeding, and children number were important
predictors for the behavioral stage of change.
Therefore, it seems to focus on these factors which
most of which are modiﬁable factors, in an appropriate manner in which to inﬂuencing cervical
cancer screening adherence.

Authorship contributions
EA, MM and ZT designed the research study.
MM and ZT organized the project and performed
the research EA analyzed the data and performed
statistical analysis.
EA, MM and ZT wrote the paper.
All authors approved the ﬁnal version of the
manuscript and submission of the manuscript.

Ethical approval
The research protocol was approved by the Ethics
Committee of Birjand University of Medical Sciences (Ethical code: IR.BUMS.REC.1399.192). Also,
informed consent was obtained from all of the participants before entering the study. All procedures
were performed in accordance with the Declaration
of Helsinki and the criteria of the ethics committee
of the Faculty of Medicine of the Birjand University
of Medical Sciences. Multilayer feed-forward backpropagation ANNs were used to detect the patterns
between variables using a neural network with 14
inputs and one output.
Conﬂicts of interest
The authors have no conﬂict of interest to disclose.

Acknowledgments
The authors of this study gratefully acknowledge
the Research Council of Birjand University of
Medical Sciences for funding this study (the
research Project No.: 5465).

References
[1] Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A,
Kotha SR, et al. The global burden of women's cancers: a
grand challenge in global health (London, England). Lancet
2017;389(10071):847e60.
[2] Arbyn M, Weiderpass E, Bruni L, de Sanjos
e S, Saraiya M,
Ferlay J, et al. Estimates of incidence and mortality of cervical
cancer in 2018: a worldwide analysis. Lancet Global Health
2020;8(2):e191e203.
[3] Woldetsadik AB, Amhare AF, Bitew ST, Pei L, Lei J, Han J.
Socio-demographic characteristics and associated factors
inﬂuencing cervical cancer screening among women
attending in St. Paul's Teaching and Referral Hospital,
Ethiopia. BMC Wom Health 2020;20:1e9.
[4] Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi~
neros M,
et al. Global cancer observatory: cancer today. Lyon, France:
International Agency for Research on Cancer; 2018.
[5] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA,
Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA A Cancer J Clin 2018;68(6):394e424.
[6] Mishra GA, Pimple SA, Shastri SS. An overview of prevention and early detection of cervical cancers. Indian J Med
Paediatr Oncol: Off J Indian Soc Med Paediatr Oncol 2011;
32(3):125.

E. ALLAHYARI ET AL.
ANNS FOR PREDICTING PAP SMEAR SCREENING

17

[7] Committee Opinion No. 641: human papillomavirus vaccination. Obstet Gynecol 2015;126(3):e38e43.
[8] Control CfD, Prevention. Frequently asked questions about
HPV vaccine safety. Atlanta, GA: Centers for Disease Control
and Prevention; 2013.
[9] Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A,
Rehman R, Cronje H, et al. Report on consensus conference
on cervical cancer screening and management. Int J Cancer
2000;86(3):440e7.
[10] Aggarwal P. WJCO. World 2014;5(4):775e80.
[11] Canfell K, Kim JJ, Brisson M, Keane A, Simms KT,
Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling
analysis in 78 low-income and lower-middle-income countries. Lancet 2020;395(10224):591e603.
[12] Miri MR, Moodi M, Sharif-Zadeh G-R, Malaki
Moghadam H, Miri M, Norozi E. Cognitive predictors of
cervical cancer screening's stages of change among sample of
Iranian women health volunteers: a path analysis. PLoS One
2018;13(3):e0193638.
[13] Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM,
Goodman MT, Sudenga SL, et al. UROGIN 2014 roadmap:
differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer
incidence by gender and anatomic site of infection. Int J
Cancer 2015;136(12):2752e60.
[14] Momenimovahed Z, Salehiniya H. Cervical cancer in Iran:
integrative insights of epidemiological analysis. Biomedicine
2018;8(3).
[15] Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC.
Human papillomavirus and cervical cancer. Lancet 2013;
382(9895):889e99.
[16] Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E,
L€
orincz A, Hern
andez M, et al. Risk factors for cervical
cancer among HPV positive women in Mexico. Salud Publica
Mex 2008;50:49e58.
[17] Megahed M. Saudi young females' level of knowledge
regarding cervical and breast cancer. Int J Nurs Sci 2012;2(5):
47e52.
[18] Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B,
Valencia S, et al. Human papillomavirus and related diseases
in the world. ICO Inform Centre HPV Cancer (HPV Inform
Centre) 2015;4(8).
[19] Glanz K, Rimer BK, Viswanath K. Health behavior and
health education: theory, research, and practice. John Wiley
& Sons; 2008.
[20] Tung W-C, Smith-Gagen J, Lu M, Warﬁeld M. Application of
the transtheoretical model to Cervical cancer screening in
Latina women. J Immigr Minority Health 2016;18(5):1168e74.
[21] Prochaska JO, DiClemente CC. Stages and processes of selfchange of smoking: toward an integrative model of change.
J Consult Clin Psychol 1983;51(3):390.
[22] Feng S, Li L, Cen L, Huang J. Using MLP networks to design
a production scheduling system. Comput Oper Res 2003;
30(6):821e32.
[23] Zaki MR, Varshosaz J, Fathi M. Preparation of agar nanospheres: comparison of response surface and artiﬁcial neural
network modeling by a genetic algorithm approach. Carbohydr Polym 2015;122:314e20.
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